Elanco Animal Health (ELAN) Share-based Compensation (2017 - 2026)

Elanco Animal Health (ELAN) reported Share-based Compensation of $21.0 million for Q1 2026, up 61.54% on a YoY basis from $13.0 million in Q1 2025, and up 31.25% sequentially from $16.0 million in Q4 2025.

Elanco Animal Health (ELAN) Share-based Compensation (2017 - 2026) Analysis & Trends

Elanco Animal Health (ELAN) has 10 years of Share-based Compensation data on file, last reported at $21.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Share-based Compensation rose 61.54% year-over-year to $21.0 million; the trailing twelve-month figure through Mar 2026 stood at $76.0 million (up 33.33% YoY), and the FY2025 full-year result was $68.0 million, up 23.64% from the prior year.
  • Share-based Compensation improved to $21.0 million in Q1 2026, from $16.0 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $22.0 million in Q2 2025 to a low of $9.0 million in Q2 2023.
  • A 5-year average of $14.6 million and a median of $15.0 million in 2022 frame the typical range for Share-based Compensation.
  • Across the five-year window, Share-based Compensation tumbled 47.06% in 2023 and surged 61.54% in 2026, its largest moves.
  • Tracing ELAN's Share-based Compensation over 5 years: stood at $15.0 million in 2022, then changed by 0.0% to $15.0 million in 2023, then changed by 0.0% to $15.0 million in 2024, then increased by 6.67% to $16.0 million in 2025, then jumped by 31.25% to $21.0 million in 2026.
  • Business Quant data shows ELAN's Share-based Compensation at $21.0 million in Q1 2026, $16.0 million in Q4 2025, and $17.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 43.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 25.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 125.69 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 58.30 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 56.50 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 55.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 21.00 Mn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn 7.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 21.00 Mn
Mar 31, 2026 21.00 Mn
Dec 31, 2025 16.00 Mn
Dec 31, 2025 16.00 Mn
Sep 30, 2025 17.00 Mn
Sep 30, 2025 17.00 Mn
Jun 30, 2025 22.00 Mn
Jun 30, 2025 22.00 Mn
Mar 31, 2025 13.00 Mn
Mar 31, 2025 13.00 Mn
Dec 31, 2024 15.00 Mn
Dec 31, 2024 15.00 Mn
Sep 30, 2024 15.00 Mn
Sep 30, 2024 15.00 Mn
Jun 30, 2024 14.00 Mn
Jun 30, 2024 14.00 Mn
Mar 31, 2024 11.00 Mn
Mar 31, 2024 11.00 Mn
Dec 31, 2023 15.00 Mn
Dec 31, 2023 15.00 Mn